- April 17,2019
- The PⅠ/Ⅱa clinical trial of FPP003(Antibody-inducing peptide) starts in Australia.
- February 26,2019
- FunPep is approved the PⅠ/Ⅱa clinical trial plan of FPP003 (antibody-inducing peptide) by HREC in Australia.
- February 18,2019
- FunPep contracts the joint research agreement with Shionogi for antibody-inducing peptide on pain territory.
- October 5,2018
- Announcement of fund raising through third-party allotment of new shares
- September 20,2018
- To develop antibody-inducing peptides for ankylopoietic spondylarthritis, industry-academia collaboration project selected by AMED
- August 29,2018
- Published the FunPep article on the Nikkei newspapers
- August 10,2018
- FunPep starts an AI research to develop efficiently Antibody-Inducing Peptides with Future Corp. and Osaka Univ.
- June 5,2018
- Re. functional peptide SR-0379, the P2 clinical trial notification submitted by Shionogi.
- April 9,2018
- FunPep enters into an option agreement on antibody inducing peptides with Sumitomo Dainippon Pharma.
- March 20,2018
- The new mild cleansing shampoo with a joint development between Fancl and FunPep released on March 20, 2018.
- May 15,2017
- FunPep signs the joint research agreement to develop anti-virus drug with Fujifilm.
- January 18,2017
- FunPep wins the MEXT Minister’s Award of the 10th Japan Bio Venture Award 2017.
- December 14,2016
- FunPep announces to enter into the collaboration research agreement on adjuvant with Shinogi.
- October 3,2016
- FunPep announces to be rewarded with grant from the Active Osaka Promotion Fund.
- September 16,2016
- FunPep announces to enter into the collaboration research agreement on Antibody-inducing peptides with Sumitomo Dainippon Pharma.